Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02915666
Title A Clinical Trial of Patients With Melanoma
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Texas Southwestern Medical Center
Indications

melanoma

Therapies

Dabrafenib + Digoxin + Trametinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST